研究人员呼吁采取更灵活的编辑行为，而不是突然只采用新的代谢相关脂肪性肝病（MASLD）命名法。 - Suppr

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.

作者信息

Lonardo Amedeo, Bril Fernando, Caldwell Stephen H, Eslam Mohammed, Fan Jian-Gao, Gish Robert G, Gronbaek Henning, Sanal Madhusudana Girija, Stefan Norbert, Suzuki Ayako, Targher Giovanni, Tilg Herbert, Yu Ming-Lung, Zheng Ming-Hua, George Jacob

机构信息

Azienda Ospedaliero-Universitaria, Modena, Italy.

University of Alabama at Birmingham (UAB), Birmingham, AL, United States.

出版信息

J Hepatol. 2024 May;80(5):e192-e194. doi: 10.1016/j.jhep.2024.01.012. Epub 2024 Feb 9.

DOI:10.1016/j.jhep.2024.01.012

PMID:38336589

Abstract

摘要

相似文献

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.研究人员呼吁采取更灵活的编辑行为，而不是突然只采用新的代谢相关脂肪性肝病（MASLD）命名法。

J Hepatol. 2024 May;80(5):e192-e194. doi: 10.1016/j.jhep.2024.01.012. Epub 2024 Feb 9.

MASLD: What We Have Learned and Where We Need to Go-A Call to Action.MASLD：我们所学到的和我们需要去的地方——行动呼吁。

Radiographics. 2024 Nov;44(11):e240048. doi: 10.1148/rg.240048.

From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病：争议与共识

World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.

Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature.美国青少年的纤维化和脂肪性肝病按新命名法分类。

J Pediatr Gastroenterol Nutr. 2024 Aug;79(2):229-237. doi: 10.1002/jpn3.12230. Epub 2024 May 1.

Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease.脂肪性肝病新命名法的意义及代谢相关脂肪性肝病的定义。

Aliment Pharmacol Ther. 2024 Jan;59(2):150-156. doi: 10.1111/apt.17846.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association.糖尿病患者的代谢功能障碍相关脂肪性肝病（MASLD）：筛查与早期干预的必要性。美国糖尿病协会共识报告

Diabetes Care. 2025 Jul 1;48(7):1057-1082. doi: 10.2337/dci24-0094.

ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population.谷丙转氨酶（ALT）水平、饮酒情况和代谢风险因素对普通人群的肝脏相关结局具有预后相关性。

JHEP Rep. 2024 Jul 24;6(10):101172. doi: 10.1016/j.jhepr.2024.101172. eCollection 2024 Oct.

From NAFLD to MASLD: When metabolic comorbidity matters.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病：当代谢合并症起重要作用时。

Ann Hepatol. 2024 Mar-Apr;29(2):101281. doi: 10.1016/j.aohep.2023.101281. Epub 2023 Dec 21.

Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.根据 MRI 衍生质子密度脂肪分数在健康检查中命名法的变化，非酒精性脂肪性肝病、代谢相关脂肪性肝病和代谢相关脂肪性肝炎的患病率存在差异。

Abdom Radiol (NY). 2024 Sep;49(9):3036-3044. doi: 10.1007/s00261-024-04285-w. Epub 2024 Apr 8.

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病之间的一致性

Hepatol Res. 2024 Jun;54(6):600-605. doi: 10.1111/hepr.14011. Epub 2024 Jan 17.

引用本文的文献

Long-Term Feasibility and Outcomes of a Digital Health Program to Improve Liver Fat and Cardiometabolic Markers in Individuals With Nonalcoholic Fatty Liver Disease: Prospective Single-Arm Feasibility Study.一项改善非酒精性脂肪性肝病患者肝脏脂肪和心脏代谢指标的数字健康计划的长期可行性及结果：前瞻性单臂可行性研究

JMIR Cardio. 2025 Sep 12;9:e72074. doi: 10.2196/72074.

Circulating Fibroblast Growth Factor-21 in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病患者循环成纤维细胞生长因子-21：一项系统评价和Meta分析

Curr Obes Rep. 2025 Jun 4;14(1):51. doi: 10.1007/s13679-025-00643-x.

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距：欧洲临床研究学会的共识声明

Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis.循环血管生成素样蛋白8（ANGPTL8）与代谢功能障碍相关的脂肪性肝病：最新系统评价与荟萃分析

Front Endocrinol (Lausanne). 2025 Apr 10;16:1574842. doi: 10.3389/fendo.2025.1574842. eCollection 2025.

Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study.476,124名韩国成年人中代谢功能障碍相关脂肪性肝病的特征及其肝纤维化风险：一项横断面研究

Endocrinol Metab (Seoul). 2025 Mar 27. doi: 10.3803/EnM.2024.2281.

Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies.通过组学技术解析代谢功能障碍相关脂肪性肝病

Int J Mol Sci. 2025 Feb 13;26(4):1589. doi: 10.3390/ijms26041589.

Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.睡眠时间与非酒精性脂肪性肝病风险之间的关联：一项系统评价和荟萃分析。

Prev Med Rep. 2025 Jan 9;50:102968. doi: 10.1016/j.pmedr.2025.102968. eCollection 2025 Feb.

Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南（2024年版）》

J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.

Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research.代谢（功能障碍）相关脂肪性肝病指标及其对肝脏研究的贡献。

Hepatol Int. 2024 Dec;18(6):1740-1755. doi: 10.1007/s12072-024-10731-0. Epub 2024 Oct 16.

Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus.代谢功能障碍对丙型肝炎病毒治愈患者肝脏相关事件风险的影响。

Am J Cancer Res. 2024 Apr 15;14(4):1914-1925. doi: 10.62347/EQIR8735. eCollection 2024.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献